Helping you navigate the insurance process 

We know that navigating the insurance process can seem daunting. 

That’s why, at the start of your treatment journey, we’ll assign you a dedicated OmniSource Case Manager (OCM) to help make the process as simple as possible. 

Your OCM will work closely with your doctor from day-one to help you get on treatment as quickly as possible without having to worry about insurance hurdles.

Your OmniSource Case Manager will work directly with your insurance provider

To get started, your OCM will reach out to your insurance company to make sure you’re eligible to receive Omnitrope. 

They will then work closely with your doctor to provide any Benefits Investigation (BI) and Prior Authorization (PA) information that may be needed. 

Should your insurance claim be denied, your OCM will be there to help submit an appeal on your behalf.

Save Money on Your Treatment Journey with our Co-Pay Offer

With our Co-Pay Savings Program, you may be eligible† to pay as little as $0 out-of-pocket, with a maximum benefit of up to $5,000 to be used at any time each year.

Find more information about our Co-Pay offer here. 

INDICATIONS

Omnitrope is a prescription medicine that contains human growth hormone and is used to treat:

• Children with growth failure due to growth hormone deficiency (GHD), Prader-Willi Syndrome, Small for Gestational Age, Turner Syndrome, and Idiopathic Short Stature
• Adults with either adult onset or childhood onset GHD

IMPORTANT SAFETY INFORMATION

Who should not take Omnitrope^®?

Omnitrope should not be used by children or adults that have:

• a critical illness caused by certain types of heart or stomach surgery, accidental trauma,  or a sudden and severe breathing problem (respiratory failure)
• Prader-Willi syndrome who are severely overweight or have a history of breathing problems including sleep apnea
• cancer or other tumors
• allergies to growth hormone or any of the ingredients in the medicine
• certain types of eye problems caused by diabetes
• closed bone growth plates

What should patients tell their healthcare provider before taking Omnitrope?

Patients should tell their healthcare provider about all of their medical conditions, including if they:

• have had heart or stomach surgery, trauma, or serious breathing problems
• have or have had cancer or any tumor
• have diabetes
• take any prescription and non-prescription medicines, steroids, vitamins, or herbal supplements
• are pregnant or breastfeeding, or plan to become pregnant or breastfeed

What are the most common side effects of Omnitrope?

• local reactions at the injection site (such as pain, numbness, redness and swelling)
• headaches
• swelling associated with fluid retention
• pain in joints and muscle pain
• carpal tunnel syndrome
• tingling and numbness
• high blood sugar (hyperglycemia/diabetes) and sugar in your urine (glucosuria)
• unusual skin sensations
• low levels of thyroid hormone (hypothyroidism)

Other possible side effects of Omnitrope are:

• return of tumor or cancerous growths
• headaches, changes in vision, nausea or vomiting (these may be symptoms of raised pressure in the brain which requires immediate medical attention)
• hip and knee pain or a limp in children, that can be a sign of slipped capital femoral epiphysis
• worsening of pre-existing curvature of the spine in children (scoliosis)
• increased ear infections and ear disorders in children with Turner syndrome; check for cardiovascular disorders (hypertension, stroke)
• intense pain and tenderness in the abdomen as consequence of an inflammation of the pancreas (pancreatitis)
• gasping syndrome (decreased rate of breathing) in children from high levels of benzyl alcohol (an inactive ingredient)
• Increased mortality in patients with Prader Willi and acute illness

Please see full Prescribing Information for Omnitrope

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. To report SUSPECTED ADVERSE REACTIONS, contact Sandoz Inc. at 1-800-525-8747 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch